Načítá se...
Remdesivir for treatment of COVID-19; an updated systematic review and meta-analysis
The coronavirus disease 2019 (COVID-19) pandemic has become a global health crisis. Considering the recent food and drug administration (FDA) approval of remdesivir as the first officially approved agent for COVID-19 treatment, we performed this systematic review and meta-analysis to evaluate the ef...
Uloženo v:
| Vydáno v: | Eur J Pharmacol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier B.V.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859696/ https://ncbi.nlm.nih.gov/pubmed/33549577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2021.173926 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|